Molecular interactions of toxic chlorinated dibenzo-p-dioxins and dibenzofurans with thyroxine binding prealbumin

Journal of Medicinal Chemistry
1985.0

Abstract

The interactions of 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds with prealbumin, a model for the nuclear thyroid hormone receptor, have been studied with use of computer graphics and predictions made regarding relative binding affinities for such structures. These modeling predictions were tested by experimentally measuring the binding affinities of dioxin and furan analogues. The results were in general agreement with the modeling predictions and demonstrated that such compounds could be effective competitive binding ligands for thyroxine-specific binding sites in prealbumin. The computer modeling work also demonstrates the importance of lateral chlorine substitution in the binding of these toxic compounds. The prealbumin interaction model should be of use in investigating the structure-toxicity relationships of these classes of toxic compounds. Thus, if prealbumin is a model for the nuclear thyroid hormone receptor, this work would also have major implications bearing on the mechanism of dioxin toxicity and the potential of these compounds to function as potent and persistent thyroxine agonists. A new cooperative receptor mechanism for dioxin toxic action is proposed.

Knowledge Graph

Similar Paper

Molecular interactions of toxic chlorinated dibenzo-p-dioxins and dibenzofurans with thyroxine binding prealbumin
Journal of Medicinal Chemistry 1985.0
Structurally specific binding of halogenated biphenyls to thyroxine transport protein
Journal of Medicinal Chemistry 1986.0
Polychlorinated biphenyls and related compound interactions with specific binding sites for thyroxine in rat liver nuclear extracts
Journal of Medicinal Chemistry 1987.0
Computer graphics in drug design: molecular modeling of thyroid hormone-prealbumin interactions
Journal of Medicinal Chemistry 1982.0
Thyroxine analogs. 23. Quantitative structure-activity correlation studies of in vivo and in vitro thyromimetic activities
Journal of Medicinal Chemistry 1977.0
Voronoi binding site model of a polycyclic aromatic hydrocarbon binding protein
Journal of Medicinal Chemistry 1990.0
Thyroid hormone analogs. Synthesis of 3'-substituted 3,5-diiodo-L-thyronines and quantitative structure-activity studies of in vitro and in vivo thyromimetic activities in rat liver and heart
Journal of Medicinal Chemistry 1988.0
Analogues of doxanthrine reveal differences between the dopamine D1 receptor binding properties of chromanoisoquinolines and hexahydrobenzo[a]phenanthridines
European Journal of Medicinal Chemistry 2012.0
Binding mode of 6ECDCA, a potent bile acid agonist of the farnesoid X receptor (FXR)
Bioorganic & Medicinal Chemistry Letters 2003.0
Structure−Activity Relationships in 1,4-Benzodioxan-Related Compounds. 9. From 1,4-Benzodioxane to 1,4-Dioxane Ring as a Promising Template of Novel α<sub>1D</sub>-Adrenoreceptor Antagonists, 5-HT<sub>1A</sub>Full Agonists, and Cytotoxic Agents
Journal of Medicinal Chemistry 2008.0